

Dr Kieron Lim
Senior Consultant Gastroenterologist & Hepatologist
MBBS, University of London, Member, Royal College of Physicians (UK), Fellow, Academy of Medicine (Gastroenterology) Singapore, Fellow, Royal College of Physicians (Edinburgh)
A pancreatic cancer diagnosis can leave patients and their families facing difficult questions about what comes next, particularly when they are anxious to begin treatment as soon as possible. However, determining the most appropriate treatment approach requires careful consideration of several factors, including the stage of the cancer.
While the stage of your diagnosis is not the only factor guiding treatment decisions, knowing how it influences the available options can help patients and their families make sense of treatment recommendations and have more informed discussions with their healthcare team.
As early detection of pancreatic cancer can be challenging, some patients are only diagnosed after the disease has progressed. This makes staging particularly important in establishing how far the cancer has advanced and which treatment options may be suitable.
Pancreatic cancer is generally classified into stages I–IV based on the extent of the tumour, lymph node involvement and whether the cancer has spread to distant organs. Earlier-stage cancers may still be suitable for surgical removal, while more advanced cancers may require a greater focus on controlling disease progression and managing symptoms.
Stage I pancreatic cancer is confined to the pancreas, without spreading to nearby lymph nodes or distant organs. Because the cancer remains localised, surgery may offer an opportunity to remove the tumour completely, provided its position allows for safe removal and the patient is medically fit.
Chemotherapy may also be recommended before or after surgery, depending on the patient's condition and treatment plan. Chemotherapy before surgery aims to treat cancer cells that may have spread beyond the pancreas and improve surgical outcomes, while chemotherapy after surgery aims to eliminate any remaining cancer cells and reduce the risk of recurrence.
At stage II, pancreatic cancer has spread beyond the pancreas into nearby tissues or regional lymph nodes, but has not reached distant organs. Surgery may still be an option, but treatment often involves a combination of approaches.
Treatment planning considers the tumour's relationship to surrounding structures, particularly nearby blood vessels, and the likelihood of removing all visible cancer. Where surgery is feasible, it may be followed by chemotherapy. If there is concern about achieving complete removal, chemotherapy may be recommended first, with further imaging used to assess the tumour's response before proceeding with surgery.
Stage III pancreatic cancer involves more extensive regional disease, including spread to four or more nearby lymph nodes or growth into major blood vessels surrounding the pancreas. The cancer has not spread to distant organs, but involvement of these structures can make complete surgical removal difficult or impossible.
Chemotherapy is commonly considered when the cancer cannot initially be removed through surgery. Radiation therapy may also be considered in selected cases to help control cancer growth in the affected area.
Doctors may reassess the cancer after this initial treatment to determine whether surgery has become feasible. If the tumour remains unsuitable for removal, treatment generally focuses on slowing disease progression, controlling cancer growth in the affected area and relieving symptoms or complications as they arise.
Stage IV pancreatic cancer means cancer cells have spread beyond the pancreas and its surrounding region to distant sites, commonly the liver, lungs or lining of the abdominal cavity. These secondary tumours are known as metastases.
Because cancer is present in multiple locations, removing the original pancreatic tumour would not eliminate the disease elsewhere in the body. Treatment therefore centres on systemic therapies, such as chemotherapy, which circulate throughout the body to help slow cancer progression.
Supportive and palliative care are also important, particularly when patients experience pain, jaundice, digestive difficulties or nutritional problems. These measures can be provided alongside cancer-directed treatment to relieve symptoms and help maintain quality of life.
Even when patients are diagnosed at the same stage, the location of the pancreatic tumour can affect which treatments are suitable. Doctors assess the tumour's position and its relationship with surrounding structures to determine whether surgery or other forms of care may be considered.
Key considerations include:
While stage and tumour location provide an important basis for treatment planning, doctors also consider the patient's individual circumstances before recommending surgery, chemotherapy or other forms of care.
These factors may include:
For example, surgery may be technically possible for an early-stage tumour, but a patient with significant underlying health conditions may not be suitable for the procedure. In such cases, doctors may discuss alternative treatment approaches.
Pancreatic cancer treatment planning may therefore involve a multidisciplinary team, including gastroenterologists, surgeons, medical oncologists, radiation oncologists and other healthcare professionals. By considering the cancer's characteristics alongside the patient's health and treatment priorities, the team can recommend an approach suited to their clinical needs and circumstances.

Understanding the stage of pancreatic cancer provides an important starting point for treatment planning. If you are exploring pancreatic cancer treatment in Singapore, a specialist assessment can help establish which approaches may be suitable for your condition.
At Kieron Lim Gastroenterology, Senior Consultant Gastroenterologist & Hepatologist Dr Kieron Lim can assess a tumour’s characteristics, review your overall health and discuss the potential benefits and limitations of available treatment options. These findings can help guide decisions about the most appropriate course of care and whether further specialist treatment is required.
With more than 20 years of clinical experience in Singapore, Dr Lim is able to support patients in understanding their diagnosis and navigating appropriate care options. If you have been diagnosed with pancreatic cancer or require further assessment, book an appointment with Dr Lim today.

Meet Our Doctor
Dr Kieron Lim
Senior Consultant Gastroenterologist & Hepatologist
MBBS, University of London Member, Royal College of Physicians (UK) Fellow, Academy of Medicine (Gastroenterology) Singapore Fellow, Royal College of Physicians (Edinburgh)
Dr Kieron Lim is a senior consultant gastroenterologist & hepatologist who provides comprehensive care for patients with gastrointestinal conditions in Singapore. His expertise extends to disorders affecting the oesophagus, stomach, colon, liver, pancreas and gallbladder. Through his experience, Dr Lim enhances patient outcomes by facilitating early detection and timely medical interventions.